Is Ozempic and Semaglutide the Same?

Ozempic is a brand name for semaglutide, so is Ozempic and semaglutide the same? Yes — same drug. Here's how semaglutide differs from tirzepatide.

ARTICLE OVERVIEW

Ozempic is a brand name for semaglutide, so is Ozempic and semaglutide the same? Yes — same drug. Here's how semaglutide differs from tirzepatide.

Yes — Ozempic and semaglutide are the same drug. Ozempic is a brand name, and semaglutide is the generic name of the active ingredient inside it. Every Ozempic pen contains semaglutide, but not every semaglutide product is Ozempic.

Semaglutide also appears in Wegovy, Rybelsus, and compounded products. Tirzepatide, sold as Mounjaro and Zepbound, is a different molecule that is often confused with semaglutide.

Ozempic Is a Brand Name; Semaglutide Is the Molecule

Semaglutide is a GLP-1 receptor agonist. It mimics a gut hormone that slows stomach emptying, increases feelings of fullness, and helps regulate blood sugar and appetite.

Manufacturers market the same molecule under different brand names depending on what the FDA approved it to treat. Ozempic is approved for type 2 diabetes. Wegovy is approved for chronic weight management. Rybelsus is an oral tablet approved for type 2 diabetes.

Brand nameActive ingredientFormFDA-approved use
OzempicSemaglutideWeekly injectionType 2 diabetes
WegovySemaglutideWeekly injectionChronic weight management
RybelsusSemaglutideDaily oral tabletType 2 diabetes
MounjaroTirzepatideWeekly injectionType 2 diabetes
ZepboundTirzepatideWeekly injectionChronic weight management

If you are asking is semaglutide the same as ozempic or wegovy, the answer is that all three share one active ingredient while carrying different approvals, doses, and instructions.

Is Ozempic Tirzepatide or Semaglutide?

Ozempic is semaglutide, not tirzepatide. The two molecules belong to the same broad family of incretin drugs, but they are not interchangeable.

Semaglutide targets one receptor: GLP-1. Tirzepatide targets two: GIP and GLP-1. That second target is why Mounjaro and Zepbound are described as dual agonists.

Common mix-ups, answered

  • Is Mounjaro a semaglutide or tirzepatide? Mounjaro is tirzepatide.
  • Is Zepbound a tirzepatide or semaglutide? Zepbound is tirzepatide.
  • Is Ozempic a semaglutide or tirzepatide? Ozempic is semaglutide.
  • Is semaglutide the same as Zepbound? No. Zepbound contains tirzepatide.

The next question many people type is is mounjaro the same as semaglutide, and the answer is no: Mounjaro's active ingredient is tirzepatide. A similar search, is tirzepatide the same as ozempic, has the same answer.

Semaglutide vs. Tirzepatide at a Glance

FeatureSemaglutideTirzepatide
Receptor targetsGLP-1GIP and GLP-1
Brand namesOzempic, Wegovy, RybelsusMounjaro, Zepbound
Typical scheduleOnce weekly (Rybelsus is daily oral)Once weekly injection
First FDA approval20172022
Common side effectsNausea, vomiting, diarrhea, constipationNausea, vomiting, diarrhea, constipation

Both drugs carry a boxed warning about thyroid C-cell tumors seen in rodents, and neither is approved for people with a personal or family history of medullary thyroid cancer.

Compounded Semaglutide and Tirzepatide Are Different Products

Compounded semaglutide and compounded tirzepatide are prepared by compounding pharmacies and are not FDA-approved. Their strength, salt form, and inactive ingredients can differ from the brand-name versions.

When people compare those products, what is the difference between semaglutide and tirzepatide compound formulas usually comes down to the active molecule and the receptors it targets.

Can You Take Semaglutide and Tirzepatide Together?

Not as routine practice. Patients ask can you take semaglutide and tirzepatide at the same time, and the standard answer is no — the combination has not been studied or approved, and stacking two GLP-1-based drugs raises the risk of severe nausea, vomiting, and dehydration.

Switching from one to the other is different. Some clinicians move a patient from semaglutide to tirzepatide, or the reverse, using a washout period and careful dose titration.

Safety and Side Effects to Know

  • Common effects include nausea, vomiting, diarrhea, constipation, and stomach pain, especially during dose increases.
  • Serious but rare risks include pancreatitis, gallbladder disease, and kidney injury from dehydration.
  • These drugs are prescription-only, and doses should be changed under medical supervision.

Tell your prescriber about all medications you take, including insulin and sulfonylureas, because combining them can lower blood sugar too far.

How to Confirm Which Drug You Actually Have

Check the generic name printed on the carton and the pen or tablet label. If the label says semaglutide, the product is semaglutide regardless of the brand name on the box.

If the label says tirzepatide, it is a different drug from Ozempic and Wegovy, even though the injection schedule looks similar.

Ozempic and semaglutide are the same medication; Ozempic is simply one brand of semaglutide. Mounjaro and Zepbound are tirzepatide and are not semaglutide. Any decision to start, stop, or switch between these drugs belongs with a licensed healthcare professional.

RELATED PEPTIDE TOPICSemaglutide peptide

Frequently Asked Questions

Is Ozempic the same as semaglutide?

Yes. Ozempic is a brand name for semaglutide, which is the generic name of the active ingredient. Other brand names for the same molecule include Wegovy and Rybelsus, but each has different FDA-approved uses and dosing.

Is Mounjaro a semaglutide or tirzepatide?

Mounjaro is tirzepatide, not semaglutide. Tirzepatide targets both GIP and GLP-1 receptors, while semaglutide targets only GLP-1. Zepbound is also tirzepatide, approved for chronic weight management.

Is Zepbound the same as semaglutide?

No. Zepbound contains tirzepatide and is approved for chronic weight management, while semaglutide is sold as Ozempic, Wegovy, and Rybelsus. They are related incretin drugs but different molecules with different receptor targets.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.